Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001181332 | SCV001346455 | likely benign | Familial hypercholesterolemia | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001201281 | SCV001372400 | likely benign | not specified | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001181332 | SCV001668391 | likely benign | Familial hypercholesterolemia | 2024-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446987 | SCV002734058 | likely benign | Cardiovascular phenotype | 2019-11-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000508706 | SCV004820115 | likely benign | Hypercholesterolemia, familial, 1 | 2023-05-31 | criteria provided, single submitter | clinical testing | |
GENin |
RCV001181332 | SCV005441709 | likely benign | Familial hypercholesterolemia | 2023-10-20 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508706 | SCV000606017 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |